Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
18.09
-0.03 (-0.17%)
At close: Sep 17, 2025, 3:59 PM
18.24
0.83%
Pre-market: Sep 18, 2025, 04:34 AM EDT

Summit Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
104.86M 71.42M 348.61M 71.79M
Short-Term Investments
307.49M 114.82M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.55M 5.28M 577K 170K
Receivables
557K 848K 6.12M 24.32M
Inventory
n/a n/a 301.5M 7.16M
Other Current Assets
10.84M 181K 300.49M 1.2M
Total Current Assets
423.75M 189.71M 656.71M 97.31M
Property-Plant & Equipment
7.4M 6.06M 5.08M 3.48M
Goodwill & Intangibles
1.86M 1.89M 1.8M 12.41M
Total Long-Term Assets
11.81M 13.24M 7.46M 16.06M
Total Assets
435.56M 202.95M 664.17M 113.37M
Account Payables
4.64M 2.67M 355K 4.37M
Deferred Revenue
n/a n/a n/a 7.94M
Short-Term Debt
n/a n/a 19.77M 284.24K
Other Current Liabilities
33.33M 9.5M 6.3M 5.31M
Total Current Liabilities
41.73M 20.41M 38.78M 25.62M
Long-Term Debt
n/a 100M 494.54M n/a
Other Long-Term Liabilities
1.63M 1.56M 1.43M 3.22M
Total Long-Term Liabilities
5.08M 104.85M 498.73M 4.47M
Total Liabilities
46.81M 125.26M 537.51M 30.09M
Total Debt
7.22M 106.1M 518.76M 2.78M
Book Value
388.75M 77.69M 126.65M 83.28M
Book Value Per Share
0.54 0.13 0.66 0.90
Common Stock
7.38M 7.02M 2.11M 980K
Retained Earnings
-1.21B -993.26M -378.33M -299.55M
Comprehensive Income
-2.29M -2.45M -1.89M -2.2M
Shareholders Equity
388.75M 77.69M 126.65M 83.28M
Total Investments
307.49M 114.82M n/a n/a